26.02.2025 17:16:09

Estée Lauder Partners With Serpin Pharma To Advance Skin Care Innovation

(RTTNews) - Estee Lauder Companies (EL), Wednesday announced that it has partnered with biotechnology firm Serpin Pharma to explore using advanced anti-inflammatory research in skin care products.

Serpin Pharma's proprietary technology, based on SERPIN proteins, enhances the body's natural healing process to reduce inflammation, skin aging, and sensitivity.

The collaboration supports Estee Lauder's 'Beauty Reimagined' strategy, which focuses on innovative, fast-to-market solutions. Ongoing scientific studies aim to apply this technology to cosmetic products for visible improvements in skin health.

EL is currently trading at $74.27, up 0.45 percent or $0.34 on the New York Stock Exchange.

Analysen zu Estée Lauder Companies Inc. (ELC) (Estee Lauder)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel